605680-52-2

Basic information

• Product Name: 3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt
• Synonyms: 3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt;Benzonitrile, 3-[2-amino-1-[(4-chlorophenyl)methyl]propyl]-, hydrochloride;3-[2-aMino-1-[(4-chlorophenyl)Methyl]propyl]-;3-[3-amino-1-(4-chlorophenyl)butan-2-yl]benzonitrile:hydrochloride
• CAS NO: 605680-52-2
• Molecular Formula: C₁₇H₁₇ClN₂*ClH
• Molecular Weight: 321.249
• Mol File: 605680-52-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt(605680-52-2)
• EPA Substance Registry System: 3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt(605680-52-2)

Safety Data

• Hazardous Substances Data: 605680-52-2(Hazardous Substances Data)

Usage

Description

3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt is a chemical compound with potential antineoplastic activity, used in the research and development of pharmaceuticals. It is a salt form of a compound that may inhibit the growth of tumors and is being studied for its potential use in the treatment of cancer, particularly breast cancer. Its structure contains a benzene ring with a butylamine group, an amino group, a nitrile group, and a chloride ion, showing promise as a potential candidate for further study in the development of new cancer treatments.
Used in Pharmaceutical Industry:
3-(3-amino-1-(4-chlorophenyl)butan-2-yl)benzonitrile HCl salt is used as a research compound for the development of new cancer treatments due to its potential antineoplastic properties. Its unique structure, including a benzene ring, butylamine group, amino group, nitrile group, and chloride ion, makes it a promising candidate for further study and potential application in cancer therapy.

Downstream Products

• 848983-06-2 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-3,5-dichloro-benzenesulfonamide 

Relevant articles and documents

SUBSTITUTED ESTERS AS CANNABINOID-1 RECEPTOR MODULATORS

Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present in

SUBSTITUTED SULFONAMIDES

The substituted sulfonamides of the invention are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

SUBSTITUTED ARYL AMIDES

Novel compounds of structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as psychotropic drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson s disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as, the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.